Investment in Prevention Health Care Delivery Research by the National Institutes of Health
Datos Bibliográficos
| ID | 9101488 |
|---|---|
| Autores | Luis F Ganoza (Office of the Director, autor de correspondencia), Jennifer Villani (0000-0003-2337-2504, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD), Carrie N Klabunde (Office of the Director, autor de correspondencia) |
| Año | 2023 |
| Volumen | 61 |
| Número | 2 |
| Páginas | 75-80 |
| Fecha de publicación | 2023-02-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000001809 |
| PMID | 36630558 |
| OpenAlex | W4315754199 |
| Idioma | EN |
| Referencias citadas | 11 |
BACKGROUND: Research assessing the delivery of preventive health care has considerable potential for improving health outcomes and reducing health care costs for the United States population. OBJECTIVE: To characterize the prevention health care delivery research grant portfolio supported by the National Institutes of Health (NIH). MATERIALS AND METHODS: A random sample of 14,523 NIH research projects funded during 2012-2019 was selected and coded for various study topics using a structured taxonomy. We analyzed the subset of prevention research projects, for which health care delivery was identified as an independent or dependent variable, including study characteristics and funding trends. RESULTS: Overall, 11.2% of NIH-funded prevention research projects were relevant to health care delivery. Of these projects, 68.6% assessed access to care, 53.4% examined quality, and 27.1% assessed costs. Over the study period, the percentage of funded prevention research projects involving health care delivery increased from 10.9%-15.1%. Over half of the projects assessed research related to the prevention of a new health condition, identification of risk factors, or health promotion (55.5%), whereas < half addressed prevention of disease progression/recurrence (40.4%), screening for early disease (20.2%), or screening for risk factors (1.4%). human immunodeficiency virus/acquired immune deficiency syndrome, cancer, and substance use were the most prevalent health topics studied, whereas other topics-such as lung diseases and Alzheimer disease-were less frequently studied. CONCLUSIONS: Health care delivery research comprises a modest portion of the NIH prevention research portfolio and is mostly focused on access and quality of care; cost-related analyses are less prevalent.human immunodeficiency virus/acquired immune deficiency syndrome, cancer, and substance use are frequently studied health topics in this portfolio
Environmental health · Family medicine · Health care · Health promotion · Political science · Population · Public health · Health Policy Implementation Science · Health Promotion and Cardiovascular Prevention · Medicine · Nursing · Public Health Policies and Education · Health Policy
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |